Article
Polymorphism of apoprotein E (APOE), methylenetetrahydrofolate reductase (MTHFR) and paraoxonase (PON1) genes in patients with cerebrovascular disease.
Clinical chemistry and laboratory medicine - 1 Apr 2001
Topić E, Simundić A M, Ttefanović M, Demarin V, Vuković V, Lovrencić-Huzjan A, Zuntar I
Abstract excerpt
Although controversial, data on the genetic polymorphism of apoprotein E (APOE), methylenetetrahydrofolate (MTHFR) and paraoxonase (PON1) genes implicate their role in the development of cerebrovascular disease. The aim of this study was to assess the association of polymorphism of APOE, MTHFR and PON1 genes in 56 stroke and 36 carotid stenosis patients, and in 124 control subjects by PCR-restriction fragment...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
